Publications scientifiques

Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?

Auteurs : Kalluri M, Luppi F, Vancheri A, Vancheri C, Balestro E, Varone F, Mogulkoc N, Cacopardo G, Bargagli E, Renzoni E, Torrisi S, Calvello M, Libra A, Pavone M, Bonella F, Cottin V, Valenzuela C, Wijsenbeek M, Bendstrup E; 3rd International Summit for ILD (ISILD), Erice collaborators listed below.

Sources : Eur Respir Rev. 2021 May 25;30(160):210026. Doi: 10.1183/16000617.0026-2021.

Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)

Auteurs : Nasser M, Larrieu S, Boussel L, Si-Mohamed S, Bazin F, Marque S, Massol J, Thivolet-Bejui F, Chalabreysse L, Maucort-Boulch D, Hachulla E, Jouneau S, Le Lay K, Cottin V.

Sources : Respir Res. 2021 May 24;22(1):162. Doi: 10.1186/s12931-021-01749-1.

Inhaled Treprostinil in Group 3 Pulmonary Hypertension

Auteurs : Nasser M, Kolb M, Cottin V.

Sources : N Engl J Med. 2021 May 13;384(19):1869. Doi: 10.1056/NEJMc2103465.

Sarcoidosis-Like Cancer-Associated Granulomatosis: Characteristics and a Case-Control Comparison with Sarcoidosis

Auteurs : Pastré J, Bouvry D, Juvin K, Benattia A, Annesi-Maesano I, Valeyre D, Nunes H, Israël-Biet D.

Sources : J Clin Med. 2021 May 5;10(9):1988. Doi: 10.3390/jcm10091988.

Prevalence, predicting factors and impact of internet use by patients with idiopathic pulmonary fibrosis: A cross-sectional observational study

Auteurs : Le Garrec M, Rousseau C, Thépault F, Kerjouan M, Salé A, Jouneau S.

Sources : Respir Med Res. 2021 May;79:100818.

PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

Auteurs : Godinas L, Iyer K, Meszaros G, Quarck R, Escribano-Subias P, Vonk Noordegraaf A, Jansa P, D’Alto M, Luknar M, Milutinov Ilic S, Belge C, Sitbon O, Reis A, Rosenkranz S, Pepke-Zaba J, Humbert M, Delcroix M.

Sources : Orphanet J Rare Dis. 2021 May 1;16(1):196. Doi: 10.1186/s13023-021-01752-1.

Combined pulmonary fibrosis and emphysema in alpha-1-antitrypsin deficiency

Auteurs : Le Beller A, Nasser M, Traclet J, Blanchet-Legens AS, Kannengiesser C, Mornex JF, Cottin V.

Sources : Respir Med Res. 2021 May;79:100819. Doi: 10.1016/j.resmer.2021.100819.

[Allergic Broncho-Pulmonary Aspergillosis (ABPA) in cystic fibrosis: Mechanisms, diagnosis and therapeutic options]

Auteurs : Bui S, Dournes G, Fayon M, Bouchet S, Burgel PR, Macey J, Murris M, Delhaes L.

Sources : Rev Mal Respir. 2021 May;38(5):466-476. Doi: 10.1016/j.rmr.2021.04.004.

Methylprednisolone pulse treatment improves ProSP-C trafficking in twins with SFTPC mutation: An isoform story?

Auteurs : Delestrain C, Aissat A, Simon S, Tarze A, Duprat E, Nattes E, Costes B, Delattre V, Finet S, Fanen P, Epaud R.

Sources : Br J Clin Pharmacol. 2021 May;87(5):2361-2373. Doi: 10.1111/bcp.14645.

Impact of the COVID-19 lockdown on patients suffering from idiopathic interstitial pneumonia.

Auteurs : Beltramo G, Cransac A, Favrolt N, Spanjaard M, Zeller M, Cottin Y, Boulin M, Bonniaud P.

Sources : Respir Med Res. 2021 May;79:100808. Doi: 10.1016/j.resmer.2020.100808.